Care to Translate AB and Bayer Vital GmbH announce strategic partnership to enhance multilingual healthcare access for patients with coagulation disorders.
2024-09-24
Pressrelease
Care to Translate AB, a Swedish company, known for its innovative medical translation solutions, is pleased to announce a new partnership in the field of hemophilia with Bayer Vital GmbH, the German distribution arm of the Bayer Group, specializing in the development and distribution of pharmaceuticals in Germany.
This strategic collaboration aims to improve access to healthcare information for patients with coagulation disorders through the integration of a comprehensive, specialized library into Care to Translate’s flagship product, the Care to Translate app. The app serves as a medical translator designed for healthcare professionals and patients, ensuring vital medical information is accessible in multiple languages.
A major healthcare barrier is the lack of information available in patients' native languages. This limitation undermines patients’ fundamental rights to fully understand their medical conditions, treatments, and care procedures. Language barriers hinder effective communication between healthcare professionals and patients, reducing treatment adherence and preventing informed decision-making. This gap not only compromises the quality of care but also perpetuates health inequities and places an additional burden on healthcare staff.
In the field of coagulation disorders, effective communication between healthcare staff and patients is crucial, as these conditions often require precise, ongoing management and patient adherence to treatment plans. Misunderstandings due to language barriers can lead to incorrect medication use, missed treatments, or failure to recognize serious complications like bleeding events. Clear communication ensures that patients fully understand their condition, treatment options, and necessary precautions, which is vital for reducing risks, improving outcomes, and ensuring patient safety in this sensitive area of health care.
“Addressing this issue is crucial for providing comprehensive and equitable care to all patients." says Christian Lauterbach, Head of Bayer Vital.
"By developing a specialized library within the Care to Translate platform focused on coagulation disorders, the partnership between Bayer and Care to Translate seeks to bridge this gap and empower both healthcare professionals and patients with accurate, multilingual medical information”, emphasizes Christian Lauterbach.
In the field of Hemophilia alone, it is estimated that up to 15% of patients in Germany require language assistance. In absence of adequate interpreter services, healthcare providers report that patients often need to bring family members or interpreters to receive language support. Free digital translation tools are not recommended, as they often provide unreliable translations and lack the necessary data security protocols to protect patient information.
“Many free digital translation tools pose significant risks due to unreliable translations and the lack of secure handling of patient data,” said Maja Magnusson, CEO of Care to Translate.
“Additionally, poor internet access in certain areas further limits the use of these tools. In contrast, Care to Translate provides a promising alternative. The app offers medically quality-assured translations in 45 languages, is accessible offline, and, importantly, does not store any patient data.
“At Bayer, we are dedicated to improving the lives of patients through innovation and collaboration." says Lauterbach.
"Our partnership with Care to Translate is an exciting opportunity to underline our commitment for the hemophilia community in Germany, ensuring physicians can provide patients with the best possible care, regardless of language barriers,” added Lauterbach.
Maja Magnusson, CEO of Care to Translate, commented, “We are thrilled to collaborate with Bayer in expanding our medical translation offerings. This partnership will not only help healthcare professionals communicate more effectively with their patients but also empower patients to make informed decisions about their treatment and care.”
“Partnering with Bayer is a significant milestone for us.” says Maja Magnusson.
“By combining our specialized product and expertise with Bayer’s extensive knowledge and network in coagulation disorders, we’re developing a highly specialized library to meet the highest standards of medical accuracy and relevance. This collaboration not only strengthens our current offering but also paves the way for continuous collaboration across various fields and geographical markets, creating countless opportunities to drive innovation and improve patient care on a larger scale.”
Care to Translate AB is a Swedish company dedicated to bridging language gaps in health care. Their Care to Translate app offers multilingual medical translation solutions, empowering healthcare professionals and patients with the tools to communicate effectively, regardless of language barriers.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to www.bayer.com.
The Bayer Vital GmbH distributes the pharmaceuticals of the Consumer Health and Pharmaceuticals divisions in Germany. For more information about Bayer Vital GmbH, please visit: www.gesundheit.bayer.de.
Read the press release from Bayer here.
For more information, please contact:
Maja Lind, Marketing Manager
Email: maja.lind@caretotranslate.com
